Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review

Research To Practice | Oncology Videos · Feb 5, 2026 · 31m

Featuring an interview with Dr Terence Friedlander, including the following topics:

Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00)

KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25)

The neoadjuvant gemcitabine intravesical system TAR-200 for patients with MIBC: Primary analysis of the SunRISe-4 trial (14:07)

Circulating tumor DNA-guided therapies for MIBC (18:41)

CME information and select publications